President Trump dismissed Attorney General Pam Bondi, ending her year-long tenure marked by failed prosecutions of his favored targets and criticism over handling the Jeffrey Epstein case. Deputy Attorney General Todd Blanche will serve temporarily. Trump is considering EPA chief Lee Zeldin as Bondi's successor, per sources.

This shakeup occurs as the White House unveils 100% tariffs on branded drugs, a move targeting pharmaceutical imports that could significantly impact drug pricing and supply chains. The Justice Department's future enforcement priorities remain uncertain under new leadership, potentially altering regulatory scrutiny across industries. Analysts warn investors to watch how these shifts affect regulatory risk for healthcare companies and broader market stability.